Author:
Vercellino Giuseppe F.,Erdemoglu Evrim,Chiantera Vito,Vasiljeva Katharina,Malak Al-Hakeem,Schneider Achim,Böhmer Gerd
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology,General Medicine
Reference60 articles.
1. Mayrand MH, Duarte-Franco E, Rodrigues I, Canadian Cervical Cancer Screening Trial Study Group et al (2007) Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357:1579–1588
2. Schmidt D, Bergeron C, Denton KJ, European CINtec Cytology Study Group et al (2011) p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. Cancer Cytopathol 119:158–166
3. Arbyn M, Roelens J, Simoens C et al (2013) Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database Syst Rev 28(3):CD008054. doi: 10.1002/14651858.CD008054.pub2.i-153
4. Rijkaart DC, Berkhof J, Rozendaal L et al (2012) Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol 13:78–88
5. Massad LS, Einstein MH, Huh WK, 2012 ASCCP Consensus Guidelines Conference et al (2013) 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 121:829–846
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献